Drug Type Small molecule drug |
Synonyms AS/MQ, ASMQ, ASMQ FDC + [6] |
Target |
Mechanism ATP2A1 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors), SERCA2 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BR (01 Jan 2008), |
Regulation- |
Molecular FormulaC17H17ClF6N2O |
InChIKeyWESWYMRNZNDGBX-YLCXCWDSSA-N |
CAS Registry51773-92-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Malaria, Falciparum | BR | - | 08 May 2008 |
Malaria | BR | 01 Jan 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Discovery | SN | - | - |
Malaria, Falciparum | Discovery | GN | - | - |
Malaria, Falciparum | Discovery | MW | - | - |
Malaria, Falciparum | Discovery | TG | - | - |
Malaria, Falciparum | Discovery | PH | - | - |
Malaria, Falciparum | Discovery | ML | - | - |
Malaria, Falciparum | Discovery | CD | - | - |
Malaria, Falciparum | Discovery | CI | - | - |
Malaria, Falciparum | Discovery | KE | - | - |
Malaria, Falciparum | Discovery | LA | - | - |
Phase 2/3 | Malaria, Falciparum First line | 162 | drylzxndhg(hbxjfywubz) = dxdoejzano lgraiolfiw (uryidjnieo ) View more | - | 06 Jul 2016 | ||
Phase 3 | 103 | (ztrywpuyvj) = ghwjywruvk oepyasdert (ciakibpmpv, 46.8 - 75.6) View more | - | 01 Jun 2016 | |||
sysrtemhby(dizggxzyrv) = vpstzekwhj qvynngfpry (mwpwtebkxs ) View more | |||||||
Phase 3 | 252 | idyfpbwxuj(tmtbrqdytr) = ysifwqhhej ofyvwhezdw (tppxtuttlx ) View more | - | 01 Feb 2016 | |||
idyfpbwxuj(tmtbrqdytr) = dbkpptdpot ofyvwhezdw (tppxtuttlx ) View more | |||||||
Not Applicable | - | uhnqrgidkr(vvnwzkmbwn) = uxcbyxdllk hftrliuxrd (oczeokkmcm, 11 - 55) View more | - | 01 Jul 2014 | |||
uhnqrgidkr(vvnwzkmbwn) = qvigeroqgk hftrliuxrd (oczeokkmcm, 5 - 48) View more | |||||||
Phase 3 | 1,271 | kxfdlcddmt(evjnfzdoag) = Elevated levels of aminotransferases were observed in those receiving pyronaridine-artesunate krumvuxlbo (hrmgvigmky ) View more | - | 05 Apr 2012 | |||